FindTrial
Sign In

Clinical value of Next-Generation Sequencing

Clinical value of Next-Generation Sequencing in Patients Suffering From Sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031113
Enrollment
Unknown
Registered
2020-03-22
Start date
2020-04-01
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Case series:Nil

Sponsors

Zhongshan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. Sepsis patients who meet the sepsis 3.0 standard proposed by the international consensus of sepsis experts in 2016, i.e. patients with infection or suspected infection, can be diagnosed as sepsis when the score of sepsis related sequential organ failure assessment (sofa) increases >=2 points from the baseline; 3. The duration of ICU stay is expected to be >=24 hours; 4. Obtain informed consent and sign informed consent.

Exclusion criteria

Exclusion criteria: Participated in other clinical studies.

Design outcomes

Primary

MeasureTime frame
metagenomics next generation sequencing;—

Countries

China

Contacts

Public ContactTong Chaoyang

Zhongshan Hospital Fudan University

tong.chaoyang@zs-hospital.sh.cn+86 13681970935

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026